Crossref
A Case of Pure Red Cell Aplasia After Immune Checkpoint Inhibitor Therapy for Squamous Cell Lung Cancer
Haigan · 20.04.2026 · 66 (2) · 97-102
DOI: 10.2482/haigan.66.97 ↗Kurz gefasst
Fachartikel in der Zeitschrift Haigan, erschienen am 20.04.2026. Verfasst von Toshihiro Kuroki und 9 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kuroki, T., Kikuchi, H., Odani, Y., Ikezawa, M., Morinaga, Y., Yamashita, Y., Sato, M., Takamura, K., Wakasa, K., & Kikuchi, K. (2026). A Case of Pure Red Cell Aplasia After Immune Checkpoint Inhibitor Therapy for Squamous Cell Lung Cancer. Haigan, 66(2), 97-102. https://doi.org/10.2482/haigan.66.97
Vancouver
Kuroki T, Kikuchi H, Odani Y, Ikezawa M, Morinaga Y, Yamashita Y, et al. A Case of Pure Red Cell Aplasia After Immune Checkpoint Inhibitor Therapy for Squamous Cell Lung Cancer. Haigan. 2026;66(2):97-102. doi:10.2482/haigan.66.97
BibTeX
@article{Kuroki2026,
author = {Kuroki, Toshihiro and Kikuchi, Hajime and Odani, Yukika and Ikezawa, Masafumi and Morinaga, Yumi and Yamashita, Yu and Sato, Miki and Takamura, Kei and Wakasa, Kentaro and Kikuchi, Keisuke},
title = {A Case of Pure Red Cell Aplasia After Immune Checkpoint Inhibitor Therapy for Squamous Cell Lung Cancer},
journal = {Haigan},
year = {2026},
volume = {66},
number = {2},
pages = {97--102},
doi = {10.2482/haigan.66.97}
}
EUVIMED